153 related articles for article (PubMed ID: 10482479)
1. Epidemiological features and visual prognosis of Behçet's disease.
Ando K; Fujino Y; Hijikata K; Izawa Y; Masuda K
Jpn J Ophthalmol; 1999; 43(4):312-7. PubMed ID: 10482479
[TBL] [Abstract][Full Text] [Related]
2. Comparison of patients with Behçet's disease in the 1980s and 1990s.
Yoshida A; Kawashima H; Motoyama Y; Shibui H; Kaburaki T; Shimizu K; Ando K; Hijikata K; Izawa Y; Hayashi K; Numaga J; Fujino Y; Masuda K; Araie M
Ophthalmology; 2004 Apr; 111(4):810-5. PubMed ID: 15051217
[TBL] [Abstract][Full Text] [Related]
3. [Clinical aspects of Behçet's disease--epidemiological features and visual prognosis].
Ando K; Fujino Y; Hijikata K; Izawa Y; Masuda K
Nippon Ganka Gakkai Zasshi; 1997 Oct; 101(10):814-8. PubMed ID: 9369064
[TBL] [Abstract][Full Text] [Related]
4. The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects.
Mishima S; Masuda K; Izawa Y; Mochizuki M; Namba K
Trans Am Ophthalmol Soc; 1979; 77():225-79. PubMed ID: 397657
[TBL] [Abstract][Full Text] [Related]
5. Visual prognosis in patients with Behçet's disease receiving colchicine, systemic corticosteroid or cyclosporin.
Hayasaka S; Kawamoto K; Noda S; Kodama T
Ophthalmologica; 1994; 208(4):210-3. PubMed ID: 7970549
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease.
Kazokoglu H; Saatçi O; Cuhadaroglu H; Eldem B
Ann Ophthalmol; 1991 Apr; 23(4):148-51. PubMed ID: 2064258
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of Behçet's disease in the Indian population.
Sachdev N; Kapali N; Singh R; Gupta V; Gupta A
Int Ophthalmol; 2009 Dec; 29(6):495-501. PubMed ID: 18936879
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin-A therapy in severe uveitis of Behçet's disease.
Süllü Y; Oge I; Erkan D; Aritürk N; Mohajeri F
Acta Ophthalmol Scand; 1998 Feb; 76(1):96-9. PubMed ID: 9541443
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of Clinical Features in Japanese Patients with Behçet's Uveitis Treated in the 1990s and the 2000s.
Nakahara H; Kaburaki T; Tanaka R; Yoshida A; Takamoto M; Kawata M; Fujino Y; Kawashima H; Aihara M
Ocul Immunol Inflamm; 2020; 28(2):262-269. PubMed ID: 30806114
[No Abstract] [Full Text] [Related]
10. Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement.
Takeuchi M; Hokama H; Tsukahara R; Kezuka T; Goto H; Sakai J; Usui M
Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1147-52. PubMed ID: 15983811
[TBL] [Abstract][Full Text] [Related]
11. Ocular Behçet's Disease: Changing Patterns Over Time, Complications and Long-Term Visual Prognosis.
Accorinti M; Pesci FR; Pirraglia MP; Abicca I; Pivetti-Pezzi P
Ocul Immunol Inflamm; 2017 Feb; 25(1):29-36. PubMed ID: 26727030
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of Behçet's disease: A retrospective chart review of 26 patients.
Davari P; Rogers RS; Chan B; Nagler TH; Fazel N
J Dermatolog Treat; 2016; 27(1):70-4. PubMed ID: 26108444
[TBL] [Abstract][Full Text] [Related]
13. Late-onset Behçet's disease does not correlate with indolent clinical course: report of seven Taiwanese patients.
Tsai J; Chen GS; Lu YW; Wu CS; Lan CC
J Eur Acad Dermatol Venereol; 2008 May; 22(5):596-600. PubMed ID: 18266686
[TBL] [Abstract][Full Text] [Related]
14. Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.
Takeuchi M; Asukata Y; Kawagoe T; Ito N; Nishide T; Mizuki N
Ocul Immunol Inflamm; 2012 Jun; 20(3):193-7. PubMed ID: 22486264
[TBL] [Abstract][Full Text] [Related]
15. Clinical study on patients with Behçet's disease in Hokkaido.
Kotake S; Furudate N; Sasamoto Y; Yoshikawa K; Okamoto T; Goda C; Matsuda H
Ocul Immunol Inflamm; 1995; 3(4):237-42. PubMed ID: 22823270
[TBL] [Abstract][Full Text] [Related]
16. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behçet's uveitis.
Klaeger AJ; Tran VT; Hiroz CA; Morisod L; Herbort CP
Int Ophthalmol; 2004 Jan; 25(1):57-63. PubMed ID: 15085978
[TBL] [Abstract][Full Text] [Related]
17. Behcet's disease with uveitis in Taiwan.
Chung YM; Lin YC; Tsai CC; Huang DF
J Chin Med Assoc; 2008 Oct; 71(10):509-16. PubMed ID: 18955185
[TBL] [Abstract][Full Text] [Related]
18. Late-onset Behçet's disease: demographic, clinical, and ocular features.
Sungur G; Hazirolan D; Hekimoglu E; Kasim R; Duman S
Graefes Arch Clin Exp Ophthalmol; 2010 Sep; 248(9):1325-30. PubMed ID: 20449602
[TBL] [Abstract][Full Text] [Related]
19. [Behcet's disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments].
Chung YM; Yeh TS; Sheu MM; Chen MS; Wen MS; Tsai HY; Liao HR
J Formos Med Assoc; 1990 May; 89(5):413-7. PubMed ID: 1977855
[TBL] [Abstract][Full Text] [Related]
20. [Behçet's disease : Description and analysis of a French single-center retrospective study of 51 patients].
Francois J; Moulinet T; Neiter E; Ehrardt A; Conart JB; Angioi-Duprez K
J Fr Ophtalmol; 2021 May; 44(5):711-717. PubMed ID: 33741217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
